Browsing: Conditions

Professor Ramesh Kurukulaaratchy, professor of respiratory medicine and allergy at the University of Southampton, explains how his team’s recent work recognising distinct patterns of multimorbidity in severe asthma may help clinicians move beyond an airway-centred approach towards more holistic, multidisciplinary care

Opioid use disorder (OUD) remains a persistent and evolving public health crisis in the United States. According to the Centers for Disease Control and Prevention, the nation is currently experiencing the third wave of the opioid epidemic.1  

Dimerix, a clinical-stage biopharmaceutical company developing kidney disease treatments, recently announced that it had acquired DMX-652 from Mission Therapeutics. The acquisition adds a Phase II-ready acute kidney injury (AKI) programme with a differentiated mechanism, expanding Dimerix beyond its late-stage focal segmental glomerulosclerosis (FSGS) asset

ByAndrew Stanton Newsweek is a Trust Project member See more of our trusted coverage when you search.to see more of our trusted coverage when you search.

A parasitic disease that causes intense intestinal distress has now infected 160 people in Wisconsin, according to the state Department of Health Services. 

The US Senate Committee on Homeland Security and Governmental Affairs will vote next week on whether to hold Anthony Fauci, one of the world’s leading infectious disease experts, in contempt for his refusal to answer questions at a hearing on 29 July. He attended under a subpoena issued last month by the committee’s Republican chairman…

The world’s pandemic early-warning system is weakest in places affected by armed conflict, where the risk of outbreaks is often greatest

We recently established an external quality assessment (EQA) scheme for next-generation sequencing (NGS) diagnostics in rare neurological disorders (RND) in collaboration with the EMQN. The first assessment rounds revealed limitations and variability in the quality and completeness of genetic testing reports. To improve and harmonize reporting in NGS-based diagnostics for RND, we identified 28 topics…

Urgent action required on CDAP shortages – Trinidad Guardian Trinidad and Tobago Guardian Online Advertise With UsAbout UsListenWatch

Agios PharmaceuticalsAGIOreported second-quarter 2026 mitapivat net revenue of $44.7 million, including $40.9 million in the United States and $3.8 million outside the U.S., as the company continued the U.S. thalassemia launch of AQVESME and prepared for a potential sickle cell disease approval later this year